| Literature DB >> 26402859 |
Sam O Shepherd1, Oliver J Wilson2, Alexandra S Taylor3, Cecilie Thøgersen-Ntoumani4, Ahmed M Adlan5, Anton J M Wagenmakers1, Christopher S Shaw6.
Abstract
BACKGROUND: Within a controlled laboratory environment, high-intensity interval training (HIT) elicits similar cardiovascular and metabolic benefits as traditional moderate-intensity continuous training (MICT). It is currently unclear how HIT can be applied effectively in a real-world environment.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26402859 PMCID: PMC4581708 DOI: 10.1371/journal.pone.0139056
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Subject characteristics, body composition, exercise capacity and cardiovascular-related outcomes before and after HIT or MICT.
| HIT | Mean diff. | MICT | Mean diff. | Time effect | Time x group | |||
|---|---|---|---|---|---|---|---|---|
| Variable |
|
| (95% CI) |
|
| (95% CI) |
|
|
|
| 46 (15/31) | 42 (12/30) | 44 (15/29) | 36 (14/22) | ||||
| Age (years) | 42±11 | 43±11 | ||||||
| Body composition | ||||||||
| Height (m) | 1.68±0.09 | 1.67 ± 0.01 | ||||||
| Body mass (kg) | 78.8± 18.3 | 77.8±17.9 | -1.0 (-1.6 to -0.3) | 77.5±15.8 | 76.6±15.8 | -0.9 (-1.6 to -0.2) | <0.001 | 0.88 |
| BMI (kg.m-2) | 27.7±5.0 | 27.4±4.9 | -0.3 (-0.5 to -0.1) | 27.7±4.6 | 27.4±4.7 | -0.3 (-0.6 to -0.1) | 0.001 | 0.94 |
| Fat mass (kg) | 26.0±10.2 | 25.2±9.9 | -0.8 (-1.5 to -0.1) | 24.7±8.5 | 23.7±9.5 | -1.0 (-1.7 to -0.3) | <0.001 | 0.23 |
| Muscle mass (kg) | 50.8±13.0 | 50.6±12.5 | -0.2 (-0.8 to 0.3) | 49.7±11.5 | 49.9±11.3 | 0.2 (-0.3 to 0.8) | <0.001 | 0.06 |
| Fat mass (%) | 31.6±7.9 | 30.8±7.5 | -0.8 (-1.5 to -0.1) | 32.0±7.6 | 30.9±8.7 | -1.0 (-1.7 to -0.3) | <0.001 | 0.40 |
| Muscle mass (%) | 65.0±7.6 | 65.6±7.3 | 0.6 (0 to 1.2) | 64.7±7.4 | 65.8±8.4 | 1.1 (0.5 to 1.7) | 0.71 | 0.07 |
| Trunk fat (kg) | 13.2±5.1 | 12.8±4.9 | -0.4 (-0.9 to 0) | 13.2±4.4 | 12.6±4.9 | -0.6 (-1.1 to -0.1) | 0.001 | 0.17 |
| Leg fat (kg) | 9.0±2.9 | 8.8±2.9 | -0.2 (-0.4 to 0) | 8.9±3.5 | 8.7±3.7 | -0.2 (-0.4 to 0) | 0.02 | 0.79 |
| Exercise capacity | ||||||||
| VO2 max (L.min-1) | 2.50±0.77 | 2.71±0.78 | 0.21 (0.16 to 0.27) | 2.43±0.70 | 2.59±0.75 | 0.16 (0.10 to 0.22) | <0.001 | 0.33 |
| VO2 max (mL.min-1.kg-1) | 32.0±7.0 | 34.8±7.1 | 2.8 (2.0 to 3.6) | 31.5±7.0 | 33.9±7.5 | 2.4 (1.7 to 3.3) | <0.001 | 0.90 |
| Wmax (W) | 172±53 | 189±53 | 17 (13 to 22) | 169±43 | 190±55 | 21 (16 to 26) | <0.001 | 0.34 |
| Cardiovascular responses | ||||||||
| Systolic BP (mmHg) | 123±11 | 123±10 | 0 (-1 to 3) | 127±14 | 123±13 | -4 (-7 to -2) | 0.02 | 0.01 |
| Diastolic BP (mmHg) | 76±10 | 75±9 | -1 (-3 to 1) | 78±9 | 76±9 | -2 (-4 to 0) | 0.03 | 0.64 |
| MAP (mmHg) | 92±9 | 91±9 | -1 (-2 to 1) | 95±10 | 92±17 | -3 (-5 to -1) | 0.03 | 0.09 |
| AIx@75bpm | 16±14 | 15±13 | -1 (-2 to 1) | 18±12 | 17±12 | -1 (-2 to 1) | 0.12 | 0.66 |
| Resting HR (bpm) | 67±9 | 64±9 | -3 (-4 to -1) | 67±9 | 65±10 | -2 (-4 to -1) | 0.01 | 0.96 |
Data provided are means ± SD. BMI, body mass index; HR, heart rate; MAP, mean arterial pressure; W , maximum workload capacity.
*Indicates significant change from pre (p<0.05), when a training × group interaction was observed.
Fig 1Flow chart of the study design.
BMI body mass index, HIT high intensity interval training, MICT moderate-intensity continuous training.
Attendance to prescribed exercise sessions and time spent exercising.
| Group effect | |||
|---|---|---|---|
| Variable | HIT | MICT |
|
| Adherence (% of prescribed sessions completed) | 83±14 | 61±15 | <0.001 |
| Total number of sessions completed | 25±5 | 33±12 | <0.001 |
| Number of sessions completed (per week) | 2.6±0.4 | 3.4±1.0 | 0.02 |
| Number of supervised sessions completed | 25±5 | 21±7 | 0.01 |
| Number of unsupervised sessions completed | N/A | 11±8 | - |
| Total time spent training (min) per week (range) | 55±10 (36–65) | 128±44 (50–225) | <0.001 |
Data provided are means ± SD.
Fig 2VO2max response to HIT and MICT.
Values are presented as means ± SD. Values in parentheses represent the mean percentage change from pre-training. *Main training effect (p<0.05).
Fasting glucose, insulin and lipids before and after HIT or MICT.
| HIT | Mean diff. | MICT | Mean diff. | Time effect | Time x group | |||
|---|---|---|---|---|---|---|---|---|
| Variable |
|
| (95% CI) |
|
| (95% CI) |
|
|
| Fasting glucose (mmol.L-1) | 5.3±0.7 | 5.4±0.9 | 0.1 (-0.1 to 0.3) | 5.5±0.9 | 5.6±0.9 | 0.1 (-0.2 to 0.2) | 0.68 | 0.94 |
| Fasting insulin (μIU.mL-1) | 20.8±10.4 | 19.1±10.2 | -1.7 (-3.9 to 0.4) | 27.8±14.8 | 25.3±12.8 | -2.5 (-4.8 to -0.2) | 0.01 | 0.52 |
| ISI-HOMA | 5.0±2.8 | 4.6±2.5 | -0.4 (-1.0 to 0.2) | 7.3±4.9 | 6.6±4.1 | -0.7 (-1.3 to -0.1) | 0.01 | 0.61 |
| NEFA (mmol.L-1) | 0.67±0.29 | 0.60±0.27 | -0.07 (-0.13 to -0.01) | 0.46±0.17 | 0.41±0.16 | -0.05 (-0.12 to 0.01) | 0.01 | 0.71 |
| NEFA AUC (mmol.L-1.min-1) | 30±13 | 26±13 | -4 (-8 to -2) | 23±9 | 21±7 | -2 (-5 to 1) | 0.01 | 0.23 |
| TG (mmol.L-1) | 1.22±0.49 | 1.09±0.48 | -0.13 (-0.25 to -0.01) | 1.34±0.84 | 1.29±0.78 | -0.05 (-0.17 to 0.08) | 0.05 | 0.34 |
| Cholesterol (mmol.L-1) | 5.1±1.2 | 4.8±0.9 | -0.3 (-0.7 to -0.1) | 5.4±1.3 | 5.0±1.4 | -0.4 (-0.7 to -0.1) | 0.01 | 0.79 |
| LDL-C (mmol.L-1) | 3.0±1.1 | 2.7±1.2 | -0.3 (-0.6 to -0.1) | 2.9±1.0 | 2.6±0.9 | -0.3 (-0.5 to 0) | 0.01 | 0.73 |
| HDL-C (mmol.L-1) | 1.36±0.38 | 1.40±0.37 | 0.04 (-0.06 to 0.16) | 1.24±0.46 | 1.38±0.40 | 0.14 (0.03 to 0.25) | 0.03 | 0.25 |
| LDL-C:HDL-C ratio | 2.5±1.3 | 2.1±1.2 | -0.4 (-0.7 to 0) | 2.9±1.9 | 2.2±1.2 | -0.7 (-1.1 to -0.4) | <0.001 | 0.17 |
Data provided are means ± SD. AUC, area under the curve; HOMA, homeostatic model assessment; ISI, insulin sensitivity index; NEFA, non-esterified fatty acids; OGTT, oral glucose tolerance test; TG, triglyceride.
Fig 3Oral glucose tolerance test responses.
Plasma glucose (A) and insulin (B) concentrations during an oral glucose tolerance test, including corresponding total area under the curve (AUC, C and D, respectively) before and after HIT or MICT. Changes in insulin sensitivity as determined using the Matsuda insulin sensitivity index in response to HIT and MICT (E). Values are presented as means ± SD. *Main training effect (p<0.05). Values in parentheses represent the mean percentage change from pre-training.
Psychological health and self-reported physical activity before and after HIT or MICT and at the 3-month follow-up.
| HIT | MICT | Time effect | Time x group | |||||
|---|---|---|---|---|---|---|---|---|
| Variable (score range) |
|
|
|
|
|
|
|
|
| Perceptions of health (1–5) | 2.96 ± 1.13 | 3.44 ± 1.10 | 3.27 ± 1.35 | 3.18 ± 1.21 | 3.56 ± 1.17 | 3.33 ± 1.45 | <0.001 | 0.659 |
| Positive affect (PANAS; 1–5) | 3.60 ± 0.84 | 3.81 ± 0.92 | 3.57 ± 0.96 | 3.42 ± 0.89 | 3.89 ± 0.98 | 3.47 ± 1.02 | <0.001 | 0.209 |
| Negative affect (PANAS; 1–5) | 1.95 ± 0.83 | 1.82 ± 0.83 | 1.88 ± 0.92 | 1.97 ± 0.92 | 1.77 ± 0.83 | 1.93 ± 0.92 | 0.050 | 0.726 |
| Life satisfaction (1–7) | 4.88 ± 1.66 | 4.91 ± 1.66 | 4.73 ± 1.94 | 4.49 ± 1.84 | 4.83 ± 1.84 | 4.40 ± 2.03 | 0.105 | 0.475 |
| Subjective vitality (1–7) | 4.10 ± 1.38 | 4.65 ± 1.38 | 4.26 ± 1.66 | 4.15 ± 1.48 | 4.73 ± 1.48 | 4.29 ± 1.75 | <0.001 | 0.970 |
| Walking (IPAQ; MET min.wk-1) | 757 ± 2120 | 640 ± 2406 | 1148 ± 2591 | 1050 ± 2250 | 1311 ± 2554 | 1565 ± 2747 | 0.004 | 0.359 |
| Moderate physical activity (IPAQ; MET min.wk-1) | 213 ± 889 | 287 ± 843 | 586 ± 1971 | 289 ± 953 | 369 ± 907 | 468 ± 2117 | 0.118 | 0.575 |
| Vigorous physical activity (IPAQ; MET min.wk-1) | 335 ± 907 | 613 ± 1091 | 668 ± 1595 | 379 ± 953 | 734 ± 1146 | 685 ± 1677 | 0.020 | 0.874 |
Data provided are means ± SD.